Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by indaknownewfieon Aug 07, 2019 4:33pm
81 Views
Post# 30003882

RE:RE:WHERE MONEY DIES....

RE:RE:WHERE MONEY DIES....
MyKnight wrote: What we knew:
That is true, but we all knew that we would dillute the stock to go to phase I And II.
Everybody knew that, including myself.
And all of this under 50 Millions $, as long as we we're under 500 Millions $ this was ok with me, ready to take that risk.
This being said, the share price is now at .04$ a share.

Knowing all of this, you need to answer the most important question:
"Does it work for GVHD"   
I know the answer, YES and not just a bit better it will be the only solution.

And just to add, we also know that phase II is getting finish this month or sept at the latest.
We also have big hint that a big partner is joinning,  and he will finance the phase 3 entirelly.
(As I have explain in previous forum, big Pharma wait for Phase 2 to finish before they make their move)


What we didn't know
Thanks to the new farming law in the states, Kaly can now produce CBD from Hemp plant that's the Oregon Farm.
I don't know if your aware of the revenu of CBD are huge.
We're starting production this year 2019.
In 2020 a conservative valuation with the eclipse client will be at a minimum of 18 Millions $, and could go as high as 65 Millions $.
We divide this by 2 to work with our expertise farm in oregon.
Bonus. We're now a vertical company.

Also Kal-1816 : Is in the track of Opiod market.

So this is the story in short, knowing all of this I can assure you that I'm buying more at .04$

I've alway said in previous post that this could go at 3 Billions $ for a buy out... I believe that isn't a good price anymore...

Just a note I've been here for the last 2 years, never saw that much bashing... this is a great sign.
Do your DD


Kalytera Therapeutics, Inc. (OTCQB:KALTF) (KLY.V) has so far been a place where investors' money goes to die since it completed a reverse merger to list in Canada at the end of 2016. The stock price has decreased approximately 95% since Kalytera started trading and 90% since the start of 2018
Read more at https://stockhouse.com/companies/bullboard?symbol=v.kly&postid=30003408#QGDlEJoUCzqVubAi.99

Awesome post Knight. I have been here for over 2 years as well and will continue to buy more because of all the same reasons you listed, i am not one for pumping but  I will say that people who dont take advantage of the opportunity to load up here, IMHO, will be kicking themselves later. Small market cap right now but it could change in a hurry. Be on the train before it leaves the station. You are absolutely right that the excessive bashing at its current state is the worst since I got into this stock, that usually means something big is going to happen. 
Bullboard Posts